(4S)-4-[[3-[2-(Methylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone

CAS : 139264-35-0

Ref. 3D-FM75153

Informations sur le produit

• Nom: (4S)-4-[[3-[2-(Methylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone
• Synonymes: (4S)-4-({3-[2-(methylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, 183C91, 2-Oxazolidinone, 4-[[3-[2-(methylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-, 2-Oxazolidinone, 4-[[3-[2-(methylamino)ethyl]-1H-indol-5-yl]methyl]-, (S)-, 4-({3-[2-(methylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, 4-[[3-[2-(Methylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinon, 4-[[3-[2-(Methylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone, N-Desmethyl Zolmitriptan

Description

Rizatriptan is a selective serotonin receptor agonist that is used to treat and prevent migraine attacks. Rizatriptan binds to the 5-HT1B/1D receptors, which are located in cranial blood vessels, and causes vasoconstriction. This medication can be administered nasally or orally. A pharmacokinetic study has been performed using an analytical method of mass spectrometric with matrix effect and bioequivalence studies using a Hplc-MS/MS method. The bioanalytical method used was an LC-MS/MS method with a UV detector.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 273.33 g/mol
• Formule: C₁₅H₁₉N₃O₂
• Degré de pureté: Min. 95%